Return On Equity of UroGen Pharma Ltd. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
UroGen Pharma Ltd. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • UroGen Pharma Ltd. Return On Equity for the quarter ending 30 Sep 2025 was 249%, a 73% decline year-over-year.
  • UroGen Pharma Ltd. annual Return On Equity for 2024 was -7364%, a 6621% decline from 2023.
  • UroGen Pharma Ltd. annual Return On Equity for 2023 was 113%, a 46% decline from 2022.
  • UroGen Pharma Ltd. annual Return On Equity for 2022 was 208%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

UroGen Pharma Ltd. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 249% -683% -73% 01 Jul 2025 30 Sep 2025
Q2 2025 503% +115% +30% 01 Apr 2025 30 Jun 2025
Q1 2025 -97487% -97633% -66865% 01 Jan 2025 31 Mar 2025
Q4 2024 -7364% -7476% -6621% 01 Oct 2024 31 Dec 2024
Q3 2024 932% +823% +757% 01 Jul 2024 30 Sep 2024
Q2 2024 388% +281% +263% 01 Apr 2024 30 Jun 2024
Q1 2024 146% +2% +1.4% 01 Jan 2024 31 Mar 2024
Q4 2023 113% -96% -46% 01 Oct 2023 31 Dec 2023
Q3 2023 109% -279% -72% 01 Jul 2023 30 Sep 2023
Q2 2023 107% -2416% -96% 01 Apr 2023 30 Jun 2023
Q1 2023 144% +716% 01 Jan 2023 31 Mar 2023
Q4 2022 208% +465% 01 Oct 2022 31 Dec 2022
Q3 2022 388% +561% 01 Jul 2022 30 Sep 2022
Q2 2022 2523% +2650% 01 Apr 2022 30 Jun 2022
Q1 2022 -572% -466% -435% 01 Jan 2022 31 Mar 2022
Q4 2021 -257% -156% -155% 01 Oct 2021 31 Dec 2021
Q3 2021 -173% -81% -88% 01 Jul 2021 30 Sep 2021
Q2 2021 -128% -51% -67% 01 Apr 2021 30 Jun 2021
Q1 2021 -107% -44% -69% 01 Jan 2021 31 Mar 2021
Q4 2020 -101% -52% -105% 01 Oct 2020 31 Dec 2020
Q3 2020 -92% -45% -96% 01 Jul 2020 30 Sep 2020
Q2 2020 -76% -23% -42% 01 Apr 2020 30 Jun 2020
Q1 2020 -63% -2% -3.5% 01 Jan 2020 31 Mar 2020
Q4 2019 -49% +21% +30% 01 Oct 2019 31 Dec 2019
Q3 2019 -47% +14% +22% 01 Jul 2019 30 Sep 2019
Q2 2019 -54% -10% -23% 01 Apr 2019 30 Jun 2019
Q1 2019 -61% -26% -75% 01 Jan 2019 31 Mar 2019
Q4 2018 -70% -36% -104% 01 Oct 2018 31 Dec 2018
Q3 2018 -61% 01 Jul 2018 30 Sep 2018
Q2 2018 -44% 01 Apr 2018 30 Jun 2018
Q1 2018 -35% 01 Jan 2018 31 Mar 2018
Q4 2017 -34% 01 Oct 2017 31 Dec 2017

UroGen Pharma Ltd. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -7364% -7476% -6621% 01 Jan 2024 31 Dec 2024
2023 113% -96% -46% 01 Jan 2023 31 Dec 2023
2022 208% +465% 01 Jan 2022 31 Dec 2022
2021 -257% -156% -155% 01 Jan 2021 31 Dec 2021
2020 -101% -52% -105% 01 Jan 2020 31 Dec 2020
2019 -49% +21% +30% 01 Jan 2019 31 Dec 2019
2018 -70% -36% -104% 01 Jan 2018 31 Dec 2018
2017 -34% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.